effect overlay
activetrials
Multiple sclerosis
Multiple Sclerosis
MS CLADEN

MS Immunity Project: The role of the peripheral immune system in various forms of Multiple Sclerosis (MS)
 

HREC: 2019.265
Principal Investigator: Dr Mastura Monif
Coordinator contact: Katherine Fazzolari
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
CLOBAS

Cladribine: a multicentre LOng-term efficacy Biomarker Australian Study
 

HREC: 2019.340
Principal Investigator: Dr Mastura Monif
Coordinator contact: Katherine Fazzolari
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
Fentrepid

A phase III multicenter, randomized,double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with ocrelizumab in adult patients with primary  progressive multiple sclerosis
 

HREC: 2020.082
Principal Investigator: Dr Mark Marriott
Coordinator contact: Katherine Fazzolari
Funding: Commercial
Multiple sclerosis
Multiple Sclerosis
SARS-CoV2 antibody-seroprevalence in MS

SARS-CoV2 antibody-seroprevalence in patients with multiple sclerosis
 

HREC: 2020.305
Principal Investigator: Dr Chris Dwyer
Coordinator contact:
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
B-cell Repopulation

B-cell repopulation in patients with multiple sclerosis treated with anti-CD20 therapies
 

HREC: 2023.079
Principal Investigator: Prof Tomas Kalincik
Coordinator contact:
Funding: Non-Commercial